Serum aldosterone, MMP-9 and glycosaminoglycans levels in predicting changes of the geometry of left ventricle in patients with arterial hypertension and chronic obstructive pulmonary disease

The study was aimed to evaluate the prognostic value of serum levels of glycosaminoglycans, aldosterone and MMP-9 in the changes of left ventricular myocardium geometry in patients with arterial hypertension (AH) combined with chronic obstructive pulmonary disease (COPD). We examined 75 patients (48 men and 27 women) with AH combined with COPD. Patients were divided into 2 groups: 1 group consisted of patients with AH and COPD of II degree of bronchial obstruction (n = 37), 2 group – AH and COPD of III degree of bronchial obstruction (n = 38). Aldosterone and MMP-9 were determined by ELISA, the level of gly-cosaminoglycans – using resorcin method. While increasing of the degree of bronchial obstruction there was a gradual increase in the left ventricle parameters, progression of systolic dysfunction and increased left ventric-ular mass. In patients with AH and COPD III compared to patients with AH and COPD II there was marked increase in the levels of MMP-9 on 22,5%, chondroitin-6-sulfates – on 5,7% and decrease ща heparan sul-phates / keratan sulfates on 15,7% (p